Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer
Clinical trial NCT07180160 · RECRUITING
Trial details
- NCT number
- NCT07180160
- Sponsor
- Wenjin Yin
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-25
- Primary completion
- 2027-09-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.